×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Realizing the Value of Digital Biomarkers Across the Product Lifecycle
Session Chair(s)
John James Hall, PhD
Senior Vice President, Europe and AsiaPac
CluePoints, Belgium
How should your organization be using digital biomarkers? Do you have a roadmap for digital biomarkers? This session will share examples of best practices of how digital biomarkers can be used to add value across the product lifecycle.
Learning Objective : Demonstrate the basics of a digital biomarker and the value it can add to diagnostics and therapies across their lifecycle; Evaluate challenges in the development, deployment and reimbursement of digital biomarkers; Identify pathways to integrate digital biomarkers into their pipelines; Define the questions that organizations should answer before beginning digital biomarker development.
Speaker(s)
Panelist
Tim McCarthy, PhD, MBA
Pfizer Inc, United States
Head, Digital Medicine and Translational Imaging
Panelist
Diane Stephenson, PhD
Critical Path Institute, United States
Executive Director
Panelist
Matthew Bonam
AstraZeneca, United Kingdom
Global Head, BioPharma R&D Digital Health
Panelist
Mo Ali
GlaxoSmithKline, United States
Vice President, Digital Analytics and Performance
Have an account?